Search Results for: cancer
Exposing a tumor’s antigens to enhance immunotherapy
Successful immunotherapy for cancer involves activating a person’s own T cells to attack the tumor. But some tumors have a …Read More
Combining CAR-T cells and inhibitor drugs for high-risk neuroblastoma
Chimeric antigen receptor (CAR)-T cell therapy is a potent emerging weapon against cancer, altering patients’ T cells so they can …Read More
Blood donations help Kit manage Diamond-Blackfan anemia — so she can dance, sing, and enjoy life
Every month, Kit Murdoch needs a blood transfusion to stay alive. The 2-year-old has Diamond-Blackfan anemia, a rare genetic blood disorder …Read More
Sickle cell gene therapy and boosting fetal hemoglobin: A 75-year history
Ed. Note: This post updates an earlier post from 2018. In a landmark decision today, the Food and Drug Administration …Read More
What you should know about hemangiomas, according to a pediatric dermatologist
When parents discover that their infant has a hemangioma, a lot of questions usually follow. To find answers for the …Read More
Gold particles and light could melt venous malformations away
Venous malformations — tissues made up largely of abnormally shaped veins — are often difficult to treat, especially when located …Read More
Keeping pace: ‘Superhero’ Zachary hasn’t let a brain tumor break his stride
Zachary Sonnek, 11, loves being active, whether that means running or playing baseball, golf, or hockey. “He’s always been ‘go, …Read More
Defying the odds: Cruise’s triumph against cavernous malformations and debilitating headaches
As a toddler, Cruise — now 13 — faced a rare cancer diagnosis that came with an 11 percent chance …Read More
Making immunotherapy safe for AML
Acute myeloid leukemia (AML), the second most common leukemia in children, is hard to treat and has a five-year survival …Read More
Uncertainty surrounds ACL treatment decisions in young athletes. It shouldn’t.
It’s an injury once seen mainly in adults, yet it’s become increasingly common in younger patients. From 2000 to 2020, …Read More